Cem Parlak

Radiation Oncology

Tomotherapy

Oncology

Experience

23 years

Academic degree

Professor, Head of Tomotherapy Department, PhD, MD

Work schedule

Mon–Sun: 09:00-12:45

Address

Almaty Tomotherapy Center

Almaty, 91 Abay St., Bldg. 3

Treatment profile

Work experience

Education

Publications

2002–2007 – Research Fellow, Radiation Oncology Clinic, Kartal Training and Research Hospital, Istanbul.
2008–2009 – Radiation Oncologist, Department of Radiation Oncology, GATA Hospital, Ankara.
2009–2011 – Radiation Oncologist, Radiation Oncology Clinic, Antalya Training and Research Hospital.
2011–2016 – Associate Professor, Department of Radiation Oncology, Faculty of Medicine, Başkent University, Adana.
2016–2021 – Radiation Oncologist, Radiation Oncology Clinic, Private Hospital 'Defne', Hatay.
April 2021 – October 2021 – Associate Professor, Department of Radiation Oncology, Uganda Cancer Institute, School of Medicine, Makerere University, Kampala, Uganda.
From November 2021 to present – Head of the Tomotherapy Department, Alma Medical Group.

2001: Marmara University, Turkey, Bachelor's degree, Faculty of Medicine (language of instruction – English).
2007: Dr. Lütfi Kırdar Kartal Research & Training Hospital, PhD program, specialty in Medicine, Radiation Oncology Clinic.
2020: 'Current issues of high-tech radiotherapy of malignant tumors of specific localization', 216 h.
2022: 'Radiation protection and safety'.
2023: 'Occupational safety and protection', 'Basic Life Support (BLS)'.

1. Mayadagli A., Kocak M., Demir O., Karabulut Gul S., Ozkan A., Parlak C., Yaprak G., Gumus M. 'Elective bladder preservation in multimodal treatment of bladder cancer.' J BUON. 2012 Jul-Sep; 17(3):483-9. PMID: 23033286.
2. Mertsoylu H., Köse F., Simtiil AT, Sedef AM, Doyan O., Besen AA, Parlak C., … 'Concurrent chemoradiotherapy with vinorelbine and fractionated cisplatin in inoperable stage III NSCLC: single-center experience.' Med Sci Monit. 2015 Mar; 21:661-6. doi:10.12659/MSM.892730.
3. Topkan E., Yildirim BA., Guer OC., Parlak C., Pehlivan B., Selek U. 'Safety and efficacy of repeat single-fraction irradiation (8 Gy) in pain recurrences in patients with stage IV NSCLC after radical chemoradiotherapy.' Int J Radiat Oncol Biol Phys. 2015;91(4):774-80. doi:10.1016/j.ijrobp.2014.12.010.
4. Yildirim M., Parlak C., Sezer D., Eryilmaz R., Kaya C., Yildiz M. 'Coronary vasospasm induced by 5-Fluorouracil and its management: a clinical case.' Eurasian J Med. 2011;43(1):54-56. doi:10.5152/eajm.2011.11.
5. Parlak C., Mertsoylu H., Güler OC., Onal C., Topkan E. 'Chemoradiotherapy after surgical resection or radiosurgery with whole brain irradiation in patients with synchronous solitary brain metastases in NSCLC: a curative approach.' Int J Radiat Oncol Biol Phys. 2014;88(4). doi:10.1016/j.ijrobp.2013.12.017.

Topkan E., Parlak C., et al. 'Influence of pretreatment leukocytosis on prognosis in patients with locally advanced NSCLC receiving concurrent chemoradiotherapy.' 15th World Lung Cancer Congress, Sydney, Australia, 2013 (oral presentation).
Parlak C., Güler OC., Ozyilkan O., Topkan E. 'Surgical resection and radiosurgery of brain metastases in NSCLC: impact on survival.' 15th World Lung Cancer Congress, Sydney, 2013 (poster).
Parlak C., et al. 'Prognostic significance of tumor volume by FDG-PET-CT in patients with locally advanced pancreatic cancer.' 14th World Gastro-Oncology Congress, Barcelona, 2012.

Radiation Therapy in Management of Small-cell Lung Cancer. InTech, Croatia, 2012. ISBN: 979-953-307-070-3.
AJCC Cancer Staging Guide (2012) – translation and editing.
Bethesda Clinical Oncology Handbook (2009) – translation and editing.
Radiation Oncology – Treatment Decisions (2004) – translation and editing.
Chapters on head and neck, lung, gastrointestinal tract, bone, lymphoma, sarcoma, leukemia, and stem cell transplantation oncology.